Ain Shams University: Breast Neoplasms trials
The registry lists 23 Breast Neoplasms studies with Ain Shams University as lead sponsor. 7 are open to participants now and 1 have results posted.
Phase 2 3Phase 3 2Phase 4 1No phase 18(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer PatientsRecruitingNCT07256119Not applicable
- Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer PatientsRecruitingNCT07233499Phase 2
- Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer DetectionRecruitingNCT06970288
- "Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"RecruitingNCT06759714
- Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast SurgeryNot yet recruitingNCT06502067Not applicable
- Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer PatientsRecruitingNCT06406127Phase 4
- TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer PatientsRecruitingNCT05206396
- PECS II vs. MTP for Analgesia After MRMCompletedNCT06187909Not applicableResults posted
- Ultrasound-Guided PEC I vs SAP Block for Postoperative Analgesia in Modified Radical MastectomyCompletedNCT07388238Not applicable
- LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer DiagnosisCompletedNCT06427720
- Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian PopulationCompletedNCT06357689
- Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast CancerCompletedNCT06320392
- Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer PatientsStatus unknownNCT05733026
- Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyStatus unknownNCT05468710
- Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic TherapyStatus unknownNCT05401942Not applicable
- "Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"CompletedNCT05189535Phase 2/3
- Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast CancerActive, not recruitingNCT05169853
- Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast CarcinomaStatus unknownNCT05151224
- ABCB1 SNPs as Predictors of PIPNCompletedNCT05093023
- Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in EgyptStatus unknownNCT04569955
- Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled StudyStatus unknownNCT04012918Phase 2
- A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient SatisfactionCompletedNCT03012152Not applicable
- Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast CancerStatus unknownNCT02690636Phase 3